Virtuoso Therapeutics

Virtuoso Therapeutics is a biopharmaceutical company advancing a pipeline of novel bispecific antibodies to treat cancer. Using a differentiated approach to antibody engineering, the company designs molecules intended to overcome the limitations of existing therapies and to address major hurdles facing emerging classes of oncology treatments. Virtuoso is a venture-backed portfolio company of Canaan Partners. This profile is maintained in the API Evangelist network; the company currently publishes no public API or developer surface.

Virtuoso Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Antibodies.

Virtuoso Therapeutics’ developer surface includes engineering blog and 4 more developer resources.

8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyAntibodiesTherapeuticsLife SciencesHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/virtuoso-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Virtuoso Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: virtuoso-therapeutics
name: Virtuoso Therapeutics
description: Virtuoso Therapeutics is a biopharmaceutical company advancing a pipeline of novel bispecific antibodies to treat
  cancer. Using a differentiated approach to antibody engineering, the company designs molecules intended to overcome the
  limitations of existing therapies and to address major hurdles facing emerging classes of oncology treatments. Virtuoso
  is a venture-backed portfolio company of Canaan Partners. This profile is maintained in the API Evangelist network; the
  company currently publishes no public API or developer surface.
url: https://raw.githubusercontent.com/api-evangelist/virtuoso-therapeutics/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://virtuosotherapeutics.com/
humanURL: https://virtuosotherapeutics.com/
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biopharmaceutical
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Antibodies
- Therapeutics
- Life Sciences
- Healthcare
apis: []
common:
- type: DomainSecurity
  url: security/virtuoso-therapeutics-domain-security.yml
- type: Website
  url: https://virtuosotherapeutics.com/
- type: About
  url: https://virtuosotherapeutics.com/company/
- type: Blog
  url: https://virtuosotherapeutics.com/news/
- type: ContactUs
  url: https://virtuosotherapeutics.com/contact/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1